node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CRKL | EPO | ENSSSCP00000010768 | ENSSSCP00000008194 | CRK like proto-oncogene, adaptor protein. | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | 0.507 |
CRKL | EPOR | ENSSSCP00000010768 | ENSSSCP00000014472 | CRK like proto-oncogene, adaptor protein. | Erythropoietin receptor; Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate LYN tyrosine kinase (By similarity). | 0.633 |
CRKL | GRB2 | ENSSSCP00000010768 | ENSSSCP00000018229 | CRK like proto-oncogene, adaptor protein. | Growth factor receptor-bound protein 2 isoform 1. | 0.815 |
CRKL | IRS2 | ENSSSCP00000010768 | ENSSSCP00000052323 | CRK like proto-oncogene, adaptor protein. | Insulin receptor substrate 2. | 0.563 |
CRKL | JAK2 | ENSSSCP00000010768 | ENSSSCP00000029236 | CRK like proto-oncogene, adaptor protein. | Tyrosine-protein kinase JAK2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN- beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors [...] | 0.616 |
CRKL | LYN | ENSSSCP00000010768 | ENSSSCP00000006663 | CRK like proto-oncogene, adaptor protein. | Tyrosine-protein kinase. | 0.655 |
CRKL | RAPGEF1 | ENSSSCP00000010768 | ENSSSCP00000006127 | CRK like proto-oncogene, adaptor protein. | Rap guanine nucleotide exchange factor 1. | 0.988 |
CRKL | SHC1 | ENSSSCP00000010768 | ENSSSCP00000028571 | CRK like proto-oncogene, adaptor protein. | SHC adaptor protein 1. | 0.741 |
CRKL | VAV1 | ENSSSCP00000010768 | ENSSSCP00000033977 | CRK like proto-oncogene, adaptor protein. | Vav guanine nucleotide exchange factor 1. | 0.603 |
EPO | CRKL | ENSSSCP00000008194 | ENSSSCP00000010768 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | CRK like proto-oncogene, adaptor protein. | 0.507 |
EPO | EPOR | ENSSSCP00000008194 | ENSSSCP00000014472 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Erythropoietin receptor; Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate LYN tyrosine kinase (By similarity). | 0.997 |
EPO | GRB2 | ENSSSCP00000008194 | ENSSSCP00000018229 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Growth factor receptor-bound protein 2 isoform 1. | 0.630 |
EPO | IRS2 | ENSSSCP00000008194 | ENSSSCP00000052323 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Insulin receptor substrate 2. | 0.610 |
EPO | JAK2 | ENSSSCP00000008194 | ENSSSCP00000029236 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Tyrosine-protein kinase JAK2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN- beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors [...] | 0.891 |
EPO | LYN | ENSSSCP00000008194 | ENSSSCP00000006663 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Tyrosine-protein kinase. | 0.587 |
EPO | RAPGEF1 | ENSSSCP00000008194 | ENSSSCP00000006127 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Rap guanine nucleotide exchange factor 1. | 0.503 |
EPO | SHC1 | ENSSSCP00000008194 | ENSSSCP00000028571 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | SHC adaptor protein 1. | 0.529 |
EPO | VAV1 | ENSSSCP00000008194 | ENSSSCP00000033977 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | Vav guanine nucleotide exchange factor 1. | 0.503 |
EPOR | CRKL | ENSSSCP00000014472 | ENSSSCP00000010768 | Erythropoietin receptor; Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate LYN tyrosine kinase (By similarity). | CRK like proto-oncogene, adaptor protein. | 0.633 |
EPOR | EPO | ENSSSCP00000014472 | ENSSSCP00000008194 | Erythropoietin receptor; Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate LYN tyrosine kinase (By similarity). | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. | 0.997 |